# Guardant Health, Inc.: filings

GH · Nasdaq · CIK 1576280 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gh.md) · [Financials](/companies/gh/financials.md) · [Filings](/companies/gh/filings.md) · [Insiders](/companies/gh/insiders.md)

## Reports and events: 150 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 810, 144 99, 8-K 98, 3 37, 10-Q 24, SC 13G/A 20, SC 13G 19, 5 9, CORRESP 9, DEFA14A 9, S-8 9, 10-K 8, 424B5 8, DEF 14A 8, 3/A 6, 4/A 6, SC 13D/A 6, UPLOAD 6, D 5, SCHEDULE 13G/A 5, ARS 4, S-3ASR 3, 424B4 2, 424B7 2, CT ORDER 2, DRS 2, DRS/A 2, EFFECT 2, FWP 2, S-1 2, S-1/A 2, SCHEDULE 13G 2, 144/A 1, 5/A 1, 8-A12B 1, 8-K/A 1, CERT 1, DRSLTR 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-30 | 20:46 ET | [10-Q](/filings/0001576280-26-000037.md) | Quarterly report, period 2026-06-30 | 0001576280-26-000037 |
| 2026-07-30 | 20:08 ET | [8-K](/filings/0001576280-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-26-000036 |
| 2026-06-18 | 20:11 ET | [8-K](/filings/0001193125-26-275864.md) | 5.07 Shareholder vote results | 0001193125-26-275864 |
| 2026-05-07 | 21:16 ET | [10-Q](/filings/0001576280-26-000026.md) | Quarterly report, period 2026-03-31 | 0001576280-26-000026 |
| 2026-05-07 | 20:10 ET | [8-K](/filings/0001576280-26-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-26-000024 |
| 2026-04-28 | 20:46 ET | [DEF 14A](/filings/0001193125-26-187403.md) | Proxy statement, period 2026-06-17 | 0001193125-26-187403 |
| 2026-04-27 | 21:11 ET | [8-K](/filings/0001193125-26-182391.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-182391 |
| 2026-02-19 | 22:14 ET | [10-K](/filings/0001576280-26-000013.md) | Annual report, period 2025-12-31 | 0001576280-26-000013 |
| 2026-02-19 | 21:12 ET | [8-K](/filings/0001576280-26-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-26-000012 |
| 2026-01-12 | 11:04 ET | [8-K](/filings/0001576280-26-000004.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576280-26-000004 |
| 2025-11-07 | 22:17 ET | [8-K](/filings/0001193125-25-272592.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-272592 |
| 2025-10-29 | 21:13 ET | [10-Q](/filings/0001576280-25-000277.md) | Quarterly report, period 2025-09-30 | 0001576280-25-000277 |
| 2025-10-29 | 20:07 ET | [8-K](/filings/0001576280-25-000276.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-25-000276 |
| 2025-09-24 | 11:50 ET | [8-K](/filings/0001576280-25-000269.md) | 7.01 Regulation FD disclosure | 0001576280-25-000269 |
| 2025-09-15 | 20:11 ET | [8-K](/filings/0001576280-25-000267.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001576280-25-000267 |
| 2025-07-30 | 21:13 ET | [10-Q](/filings/0001576280-25-000246.md) | Quarterly report, period 2025-06-30 | 0001576280-25-000246 |
| 2025-07-30 | 20:08 ET | [8-K](/filings/0001576280-25-000245.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-25-000245 |
| 2025-06-20 | 20:22 ET | [8-K](/filings/0001193125-25-143681.md) | 5.07 Shareholder vote results | 0001193125-25-143681 |
| 2025-04-30 | 21:10 ET | [10-Q](/filings/0001576280-25-000136.md) | Quarterly report, period 2025-03-31 | 0001576280-25-000136 |
| 2025-04-30 | 20:11 ET | [8-K](/filings/0001576280-25-000135.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-25-000135 |
| 2025-04-29 | 20:29 ET | [DEF 14A](/filings/0001193125-25-103890.md) | Proxy statement, period 2025-06-18 | 0001193125-25-103890 |
| 2025-04-09 | 20:37 ET | [8-K](/filings/0001193125-25-076885.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-076885 |
| 2025-02-20 | 22:17 ET | [10-K](/filings/0001576280-25-000044.md) | Annual report, period 2024-12-31 | 0001576280-25-000044 |
| 2025-02-20 | 21:11 ET | [8-K](/filings/0001576280-25-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-25-000043 |
| 2025-02-14 | 22:06 ET | [8-K](/filings/0001193125-25-027362.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-027362 |
| 2025-02-07 | 11:35 ET | [8-K](/filings/0001193125-25-022242.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-022242 |
| 2025-01-13 | 21:17 ET | [8-K](/filings/0001193125-25-005319.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005319 |
| 2024-11-06 | 22:12 ET | [10-Q](/filings/0001576280-24-000261.md) | Quarterly report, period 2024-09-30 | 0001576280-24-000261 |
| 2024-11-06 | 21:08 ET | [8-K](/filings/0001576280-24-000260.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-24-000260 |
| 2024-10-24 | 21:10 ET | [8-K](/filings/0001193125-24-242960.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-242960 |
| 2024-08-23 | 20:10 ET | [8-K](/filings/0001193125-24-206179.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-206179 |
| 2024-08-07 | 21:12 ET | [10-Q](/filings/0001576280-24-000190.md) | Quarterly report, period 2024-06-30 | 0001576280-24-000190 |
| 2024-08-07 | 20:09 ET | [8-K](/filings/0001576280-24-000189.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-24-000189 |
| 2024-07-29 | 10:46 ET | [8-K](/filings/0001193125-24-186674.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-186674 |
| 2024-07-18 | 21:19 ET | [8-K](/filings/0001193125-24-181093.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-181093 |
| 2024-06-14 | 13:05 ET | [8-K](/filings/0001193125-24-161223.md) | 5.07 Shareholder vote results | 0001193125-24-161223 |
| 2024-05-31 | 20:25 ET | [8-K](/filings/0001193125-24-151836.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-151836 |
| 2024-05-24 | 11:01 ET | [8-K](/filings/0001193125-24-146510.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-146510 |
| 2024-05-09 | 20:59 ET | [10-Q](/filings/0001576280-24-000109.md) | Quarterly report, period 2024-03-31 | 0001576280-24-000109 |
| 2024-05-09 | 20:11 ET | [8-K](/filings/0001576280-24-000108.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-24-000108 |
| 2024-04-25 | 20:21 ET | [DEF 14A](/filings/0001193125-24-113951.md) | Proxy statement, period 2024-06-12 | 0001193125-24-113951 |
| 2024-03-22 | 21:10 ET | [8-K](/filings/0001193125-24-075436.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-075436 |
| 2024-02-22 | 22:23 ET | [10-K](/filings/0001576280-24-000043.md) | Annual report, period 2023-12-31 | 0001576280-24-000043 |
| 2024-02-22 | 21:10 ET | [8-K](/filings/0001576280-24-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-24-000039 |
| 2024-02-01 | 21:20 ET | [8-K](/filings/0001193125-24-021871.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-021871 |
| 2024-01-08 | 21:17 ET | [8-K](/filings/0001193125-24-004446.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-004446 |
| 2023-12-21 | 21:07 ET | [8-K](/filings/0001193125-23-301187.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-301187 |
| 2023-12-19 | 22:20 ET | [8-K](/filings/0001193125-23-298718.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-298718 |
| 2023-11-15 | 11:04 ET | [8-K](/filings/0001193125-23-277418.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-277418 |
| 2023-11-06 | 21:58 ET | [10-Q](/filings/0001576280-23-000187.md) | Quarterly report, period 2023-09-30 | 0001576280-23-000187 |

Page 1 of 3. [Older](/companies/gh/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.